Somulose Solution for Injection

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

Secobarbital sodium ; Cinchocaine Hydrochloride

제공처:

Dechra Ltd

ATC 코드:

QN05CB02

INN (국제 이름):

Secobarbital sodium ; Cinchocaine Hydrochloride

복용량:

400/25 milligram(s)/millilitre

약제 형태:

Solution for injection

처방전 유형:

VPO: Veterinary Practitioner Only as defined in relevant national legislation

치료 그룹:

Cats, Cattle, Dogs, Non food-producing horses

치료 영역:

barbiturates in combination with other drugs

치료 징후:

Neurological Preparations

승인 상태:

Authorised

승인 날짜:

2006-10-06

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Somulose Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
Clear slightly straw coloured viscous solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs, cats, horses and cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For euthanasia in dogs, cats, horses and cattle only.
4.3 CONTRAINDICATIONS
The combination product must not be used for anaesthesia, it is
non-sterile.
When used in horses or cattle do not use the carcass for animal
consumption.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Non-vascular administration may delay onset of effect, cause pain and
result in excitement.
Rarely, horses may show resistance to euthanasia and prior use of
sedation should be considered in each case (see also
under section 4.9). It is always advisable to have an alternative
method of euthanasia available.
1 ml contains:
ACTIVE SUBSTANCES:
Secobarbital Sodium (Quinalbarbitone Sodium)
400 mg
Cinchocaine Hydrochloride
25
mg
For the full list of excipients, see section 6.1
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_5_
_/_
_0_
_7_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_1_
_1_
_5_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Care should be taken not to excite the animal.
The dose is to be administered intravenously only (see also under
section